BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7895612)

  • 1. Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.
    Tzimas G; Sass JO; Wittfoht W; Elmazar MM; Ehlers K; Nau H
    Drug Metab Dispos; 1994; 22(6):928-36. PubMed ID: 7895612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
    Hummler H; Hendrickx AG; Nau H
    Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM; Jiang H; Penner JD; Heyman RA
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of retinaldehyde isomers in pregnant rats: 13-cis- and all-trans-retinaldehyde, but not 9-cis-retinaldehyde, yield very similar patterns of retinoid metabolites.
    Sass JO; Tzimas G; Elmazar MM; Nau H
    Drug Metab Dispos; 1999 Mar; 27(3):317-21. PubMed ID: 10064560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
    Kraft JC; Slikker W; Bailey JR; Roberts LG; Fischer B; Wittfoht W; Nau H
    Drug Metab Dispos; 1991; 19(2):317-24. PubMed ID: 1676630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
    Satre MA; Penner JD; Kochhar DM
    Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.
    Sass JO; Masgrau E; Saurat JH; Nau H
    Drug Metab Dispos; 1995 Sep; 23(9):887-91. PubMed ID: 8565776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G; Thiel R; Chahoud I; Nau H
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
    Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-cis-retinoyl-beta-D-glucuronide is a major metabolite of 9-cis-retinoic acid.
    Sass JO; Tzimas G; Nau H
    Life Sci; 1994; 54(6):PL69-74. PubMed ID: 8295481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
    Eckhoff C; Willhite CC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice.
    Tzimas G; Collins MD; Nau H
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):91-101. PubMed ID: 7597714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
    Shirley MA; Bennani YL; Boehm MF; Breau AP; Pathirana C; Ulm EH
    Drug Metab Dispos; 1996 Mar; 24(3):293-302. PubMed ID: 8820419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoyl-beta-glucuronide is a potent teratogen in the mouse because of extensive metabolism to all-trans-retinoic acid.
    Nau H; Elmazar MM; Rühl R; Thiel R; Sass JO
    Teratology; 1996 Sep; 54(3):150-6. PubMed ID: 8987158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
    Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
    Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 13-cis-retinoic acid by a rat liver 9000g supernatant preparation.
    Vane FM; Buggé CJ; Williams TH
    Drug Metab Dispos; 1982; 10(3):212-9. PubMed ID: 6125352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.